Sorrento Therapeutics Inc (SRNE)
0.0135
-0.01
(-32.50%)
USD |
OTCM |
May 08, 14:30
Sorrento Therapeutics Total Liabilities (Quarterly): 654.65M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 654.65M |
| March 31, 2023 | 587.48M |
| December 31, 2022 | 494.51M |
| September 30, 2022 | 485.41M |
| June 30, 2022 | 496.37M |
| March 31, 2022 | 629.44M |
| December 31, 2021 | 616.69M |
| September 30, 2021 | 621.46M |
| June 30, 2021 | 593.39M |
| March 31, 2021 | 382.73M |
| December 31, 2020 | 395.09M |
| September 30, 2020 | 456.80M |
| June 30, 2020 | 452.85M |
| March 31, 2020 | 485.33M |
| December 31, 2019 | 524.88M |
| September 30, 2019 | 554.21M |
| June 30, 2019 | 532.43M |
| March 31, 2019 | 491.36M |
| December 31, 2018 | 416.59M |
| September 30, 2018 | 364.40M |
| June 30, 2018 | 193.06M |
| March 31, 2018 | 196.01M |
| December 31, 2017 | 225.00M |
| September 30, 2017 | 346.48M |
| June 30, 2017 | 288.57M |
| Date | Value |
|---|---|
| March 31, 2017 | 283.12M |
| December 31, 2016 | 315.08M |
| September 30, 2016 | 206.56M |
| June 30, 2016 | 216.18M |
| March 31, 2016 | 184.82M |
| December 31, 2015 | 202.58M |
| September 30, 2015 | 178.51M |
| June 30, 2015 | 41.56M |
| March 31, 2015 | 31.26M |
| December 31, 2014 | 32.83M |
| September 30, 2014 | 33.14M |
| June 30, 2014 | 32.30M |
| March 31, 2014 | 31.46M |
| December 31, 2013 | 25.77M |
| September 30, 2013 | 7.104M |
| June 30, 2013 | 2.019M |
| March 31, 2013 | 1.874M |
| December 31, 2012 | 0.5842M |
| September 30, 2012 | 0.5442M |
| June 30, 2012 | 0.4157M |
| March 31, 2012 | 0.32M |
| December 31, 2011 | 0.3593M |
| September 30, 2011 | 0.472M |
| June 30, 2011 | 0.425M |
| March 31, 2011 | 1.116M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
382.73M
Minimum
Mar 2021
654.65M
Maximum
Jun 2023
527.28M
Average
524.88M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Scilex Holding Co | 274.25M |
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 456.69M |
| Shareholders Equity (Quarterly) | -205.11M |
| Debt to Equity Ratio | -0.6928 |
| Current Ratio | 0.5024 |
| Net Debt Paydown Yield | 1.11% |